OVARIAN-CARCINOMA - A REVIEW OF THE SIGNIFICANCE OF FAMILIAL RISK-FACTORS AND THE ROLE OF PROPHYLACTIC OOPHORECTOMY IN CANCER PREVENTION

被引:0
|
作者
NGUYEN, HN [1 ]
AVERETTE, HE [1 ]
JANICEK, M [1 ]
机构
[1] DIV GYNECOL ONCOL, MIAMI, FL USA
关键词
OVARIAN CANCER; FAMILY HISTORY; HEREDITARY CANCER SYNDROME; PROPHYLACTIC OOPHORECTOMY;
D O I
10.1002/1097-0142(19940715)74:2<545::AID-CNCR2820740204>3.0.CO;2-Q
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Women with a family history of ovarian cancer are at increased risk of ovarian cancer. Prophylactic oophorectomy(PO) remains the only effective method of ovarian cancer prevention. This study reviewed current data on the significance of family history and how prophylactic oophorectomy should be used in different risk groups. Approximately 7% of ovarian cancer patients have a positive family history of whom 3-9% may eventually manifest certain hereditary cancer syndromes. Women in direct genetic lineage of family cancer syndromes have up to a 50% lifetime risk of ovarian cancer. Because of the high risk, PO is indicated for women with familial cancer syndromes after childbearing or between the ages of 35-40 at the latest. The majority of women with a positive family history of ovarian cancer do not have one of the recognized syndromes. Women with one or two affected relatives have an increased lifetime risk of ovarian cancer from a baseline of 1.6 to 5-7%. This risk is not high enough to warrant PO for a large number of women. After being properly informed, the patient still chooses surgical prevention, she then receives PO. For women without a family history of ovarian cancer, the role of PO remains controversial. Assuming an annual incidence of 22,000 new cases of ovarian cancer, it is estimated that at least 1000 may be prevented if PO is diligently practiced during hysterectomy. Despite ovarian and breast cancer prevention, PO would lead to shorter life expectancy if estrogen therapy compliance were less than perfect. Thus, the decision on PO as a concurrent procedure should depend on the individual patient and her ability to comply with lifelong estrogen therapy.
引用
收藏
页码:545 / 555
页数:11
相关论文
共 47 条
  • [21] Attitudes towards risk-reducing early salpingectomy with delayed oophorectomy for ovarian cancer prevention: a cohort study
    Gaba, F.
    Blyuss, O.
    Chandrasekaran, D.
    Osman, M.
    Goyal, S.
    Gan, C.
    Izatt, L.
    Tripathi, V
    Esteban, I
    McNicol, L.
    Ragupathy, K.
    Crawford, R.
    Evans, D. G.
    Legood, R.
    Menon, U.
    Manchanda, R.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2021, 128 (04) : 714 - 726
  • [22] Risk factors for familial and sporadic ovarian cancer among French Canadians: A case-control study
    Godard, B
    Foulkes, WD
    Provencher, N
    Brunet, JS
    Tonin, PN
    Mes-Masson, AM
    Narod, SA
    Ghadirian, P
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1998, 179 (02) : 403 - 410
  • [23] Breast and ovarian cancer risk perception after prophylactic salpingo-oophorectomy due to an inherited mutation in the BRCA1 or BRCA2 gene
    Finch, A.
    Metcalfe, K.
    Lui, J.
    Springate, C.
    Demsky, R.
    Armel, S.
    Rosen, B.
    Murphy, J.
    Elit, L.
    Sun, P.
    Narod, S.
    CLINICAL GENETICS, 2009, 75 (03) : 220 - 224
  • [24] Incidence and Risk Factors of Ovarian Cancer and Breast Cancer Following Prophylactic Surgery: A Retrospective Cohort Study
    Rettenmaier, Mark A.
    Micha, John P.
    Bohart, Randy
    Epstein, Howard D.
    King, Monica M.
    Goldstein, Bram H.
    JOURNAL OF GYNECOLOGIC SURGERY, 2020, 36 (04) : 189 - 193
  • [25] Prophylactic Bilateral Salpingectomy in Preventing Ovarian Cancer in High Risk Women: A Systematic Review
    Lamzouri, Oussama
    Taheri, Hafsa
    Saadi, Hanane
    Mimouni, Ahmed
    INDIAN JOURNAL OF GYNECOLOGIC ONCOLOGY, 2025, 23 (02)
  • [26] Factors Associated with Altered Long-Term Well-Being After Prophylactic Salpingo-Oophorectomy Among Women at Increased Hereditary Risk for Breast and Ovarian Cancer
    Touboul, Cyril
    Uzan, Catherine
    Ichante, Jean Laurent
    Caron, Olivier
    Dunant, Ariane
    Dauchy, Sarah
    Gouy, Sebastien
    de Paillerets, Brigitte Bressac
    Morice, Philippe
    Delaloge, Suzette
    ONCOLOGIST, 2011, 16 (09): : 1250 - 1257
  • [27] Patient perspectives on risk-reducing salpingectomy with delayed oophorectomy for ovarian cancer risk-reduction: A systematic review of the literature
    Perez, Luiza
    Webster, Emily
    Bull, Leslie
    Brewer, Jesse T.
    Ahsan, Muhammad Danyal
    Lin, Jenny
    Levi, Sarah R.
    Cantillo, Evelyn
    Chapman-Davis, Eloise
    Holcomb, Kevin
    Rosenberg, Shoshana M.
    Frey, Melissa K.
    GYNECOLOGIC ONCOLOGY, 2023, 173 : 106 - 113
  • [28] Risk-Reducing Bilateral Salpingo-Oophorectomy for Ovarian Cancer: A Review and Clinical Guide for Hereditary Predisposition Genes
    Liu, Ying L.
    Breen, Kelsey
    Catchings, Amanda
    Ranganathan, Megha
    Latham, Alicia
    Goldfrank, Deborah J.
    Grisham, Rachel N.
    Long Roche, Kara
    Frey, Melissa K.
    Chi, Dennis S.
    Abu-Rustum, Nadeem
    Aghajanian, Carol
    Offit, Kenneth
    Stadler, Zsofia K.
    JCO ONCOLOGY PRACTICE, 2022, 18 (03) : 201 - +
  • [29] Metastatic ovarian carcinoma in breast cancer patients during risk-reducing salpingo-oophorectomy: Report of two cases
    Shakya, Prafulla
    Bajracharya, Anu
    Shrestha, Suraj
    Kharel, Sanjeev
    Maharjan, Rubina
    Shrestha, Aagon Krishna
    ANNALS OF MEDICINE AND SURGERY, 2022, 73
  • [30] Risk factors for developing both primary breast and primary ovarian cancer: A systematic review
    Ferris, Jennifer S.
    Morgan, Devon A.
    Tseng, Ashley S.
    Terry, Mary Beth
    Ottman, Ruth
    Hur, Chin
    Wright, Jason D.
    Genkinger, Jeanine M.
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2023, 190